Journal of Clinical Psychiatry Issue 73(4)

Early Recognition and Diagnosis of Multiple Sclerosis

Bipolar Disorder Maintenance Treatment: Monitoring Effectiveness and Safety

Treating ADHD: Addressing the Needs of College Students

Early Recognition and Diagnosis of Multiple Sclerosis

Bipolar Disorder Maintenance Treatment: Monitoring Effectiveness and Safety

A Roadmap for the Management of Fibromyalgia

In Memoriam: Andrew C. Leon, PhD, 1951–2012

Nonsteroidal Anti-Inflammatory Drugs in Schizophrenia: Ready for Practice or a Good Start? A Meta-Analysis

Neural and Behavioral Correlates of Peritraumatic Dissociation in an Acutely Traumatized Sample

Mortality of Neuroleptic Malignant Syndrome Induced by Typical and Atypical Antipsychotic Drugs: A Propensity-Matched Analysis From the Japanese Diagnosis Procedure Combination Database

Emotional Numbing in Posttraumatic Stress Disorder: A Functional Magnetic Resonance Imaging Study

Commentary: Would Broadening the Diagnostic Criteria for Bipolar Disorder Do More Harm Than Good? Implications From Longitudinal Studies of Subthreshold Conditions

Commentary: Lowering the Diagnostic Threshold for Bipolar Disorder: The Wrong Stuff?

An 8-Week, Randomized Controlled Trial of Atomoxetine, Atomoxetine Plus Buspirone, or Placebo in Adults With ADHD

Successful Pharmacologic Treatment of Major Depressive Disorder Attenuates Amygdala Activation to Negative Facial Expressions: A Functional Magnetic Resonance Imaging Study

Prediabetes in Patients Treated With Antipsychotic Drugs

Tobacco Use Before, At, and After First-Episode Psychosis: A Systematic Meta-Analysis [CME]

Insomnia and Objectively Measured Sleep Disturbances Predict Treatment Outcome in Depressed Patients Treated With Psychotherapy or Psychotherapy-Pharmacotherapy Combinations

Are Antipsychotics or Antidepressants Needed for Psychotic Depression? A Systematic Review and Meta-Analysis of Trials Comparing Antidepressant or Antipsychotic Monotherapy With Combination Treatment

Case Report: A Case of Akathisia After Switching From Branded to Generic High-Dose Olanzapine

The Impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on Prescribing Practices: An Analysis of Data From a Large Midwestern State

New Clinical Drug Evaluation Unit (NCDEU) Annual Meeting: A Great Opportunity for Early Career Psychiatrists

The Psychiatric Manifestations of Mitochondrial Disorders: A Case and Review of the Literature

Race and Long-Acting Antipsychotic Prescription at a Community Mental Health Center: A Retrospective Chart Review

Can People With Nonsevere Major Depression Benefit From Antidepressant Medication?

Minimum Clinically Important Difference in the Positive and Negative Syndrome Scale With Data From the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)

<span class='smallcaps'>d</span>-Cycloserine Augmentation of Behavioral Therapy for the Treatment of Anxiety Disorders: A Meta-Analysis

Reply to Artificial Rediagnosis of Psychotic Depression as Schizophrinia

Artifactual Rediagnosis of Psychotic Depression as Schizophrenia

The Conceptual Evolution of <em>DSM-5</em>